• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON IND. CIRURGICAS LTDA BD PLASTIPAK¿ 20 ML SYRINGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON IND. CIRURGICAS LTDA BD PLASTIPAK¿ 20 ML SYRINGE Back to Search Results
Catalog Number 990173
Device Problems Crack (1135); Excess Flow or Over-Infusion (1311)
Patient Problems Bradycardia (1751); Low Blood Pressure/ Hypotension (1914); Overdose (1988); Chest Tightness/Pressure (2463)
Event Date 08/13/2016
Event Type  Injury  
Manufacturer Narrative
(b)(6).Device evaluation: result - a visual inspection of 40 retention samples was performed and the reported defect of cracks were not evidenced.The customer returned one sample, which was visually inspected and a crack was noted.A review of the device history record revealed no abnormalities in the manufacture of the reported lot 5224484.The products undergo a rigorous inspection process at various stages of the production process.All inspections complied with the product specifications.Conclusion - bd was not able to duplicate or confirm the customer's indicated defect of cracks in the nozzle.Ater analyzing the history of the lot, it is noted that there are no instances of records that may be related to the defect reported by the customer.Based on information provided by the client, it can be stated that the product was not used in accordance with manufacturer's recommendations.Bd syringes manufactured in (b)(4) are not indicated for use in infusion pumps.According to the production history records the product in question is in accordance with the bd specifications.
 
Event Description
It was reported that the patient was receiving a fentanyl infusion from the suspect device on a non-bd infusion pump.The medication had been infusing between 3 and 4 hours when the patient experienced bradycardia, hypotension and chest stiffness.The infusion was stopped, the doctor administered naloxone, and the patient's ventilation was assisted with an ambu bag.It was noted that there was a crack at the location of the luer lock, "which led to a greater infusion than prescribed and worsened the child's clinical condition".The patient was discharged to the hospital sector from the pediatric icu on (b)(6) 2016 and later discharged from the hospital on (b)(6) 2016.There was no extension of the hospital stay and no permanent harm occurred to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PLASTIPAK¿ 20 ML SYRINGE
Type of Device
SYRINGE
Manufacturer (Section D)
BECTON DICKINSON IND. CIRURGICAS LTDA
550 rua cyro correia pereira
curitiba
Manufacturer (Section G)
BECTON DICKINSON IND. CIRURGICAS LTDA
550 rua cyro correia pereira
curitiba
Manufacturer Contact
brett wilko
9450 south state street
sandy, UT 84070
8015652845
MDR Report Key5970251
MDR Text Key55369542
Report Number3003916417-2016-00002
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Reporter Occupation Other
Type of Report Initial
Report Date 09/15/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/22/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/01/2020
Device Catalogue Number990173
Device Lot Number5224484
Is the Reporter a Health Professional? No
Date Manufacturer Received08/29/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/12/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age1 MO
-
-